Skip to content

Menu

Network Sub-MenuBrowse by SubjectBrowse by PublisherJoin the NetworkGet StartedSubscribeSupportContact

Search

Close

Enter Search Terms

Riley Wyberg

ID: 1b826635-2619-30fb-68c4

/

Unclaimed

/

Organization: Goodwin Procter

Celltrion and Teva’s TRUXIMA® Becomes First Interchangeable Rituximab Biosimilar in U.S.

Big Molecule Watch · July 9, 2026

Polpharma and Tuteur Enter License for the Commercialization of a Biosimilar Targeting Autoimmune Diseases in Latin America

Big Molecule Watch · June 4, 2026

International Biosimilars Updates

Big Molecule Watch · May 15, 2026

Amgen and Shanghai Henlius/Organon Settle Denosumab BPCIA Litigation

Big Molecule Watch · April 8, 2026

Samsung and Regeneron Settle Aflibercept BPCIA Case

Big Molecule Watch · February 13, 2026

Previous

12...6

Next

Claim This Record

Is this your profile? Upgrade to display your full biography, collected works, social connections, practice areas, and more.

Enhance Your Profile

Call us at 1-800-913-0988 or email sales@lexblog.com.

Facebook LinkedIn Twitter RSS

About LexBlog
The Field We Built
Library at LexBlog
Our Beliefs
Our Team
Contact LexBlog

Disclaimer
Editorial Policy
Terms of Service

Get Started
Publishing Solutions
Compass

Submit a Request
Support Center
System Status

Copyright © 2026, LexBlog, Inc. All Rights Reserved.

Law blog design & platform by LexBlog